Carlsmed, Inc. CARL
14.71 USD -1.34 (-8.35%)
At closeNov 10, 2026, 4:00 PM EST
14.71 0.00 0.00%
After hours · Nov 10, 4:00 PM ET
14.70 Day range 15.91
8.50 52-week range 17.23
- YTD
- +19.11%
- 1 year
- +16.65%
- Market cap
- 401.62M
- EPS (ttm)
- -1.08
- YTD return
- +19.11%
- 1-year return
- +16.65%
- Volume
- 109.23K
- Avg volume
- 104.37K
- Open
- 15.91
- Previous close
- 16.05
- Day's range
- 14.70 – 15.91
- 52-week range
- 8.50 – 17.23
5D +0.36 (+2.36%)
Financials — quick view
CARL Revenue — quarterly 18.94M
CARL Net income — quarterly -10.51M
CARL EPS — quarterly -0.39
News
Carlsmed Q3 Earnings Call Highlights 
Carlsmed, Inc. (CARL) Q3 2026 Earnings Call Transcript 
Carlsmed, Inc. (CARL) Reports Q3 Loss, Tops Revenue Estimates 
UPDATE: Carlsmed Q3 Adj. EPS $(0.34) Beats $(0.40) Estimate, Sales $21.554M Beat $19.154M Estimate 
Carlsmed Q3 2026 Earnings Call Transcript 
Carlsmed Q3 EPS $(0.45) Misses $(0.40) Estimate, Sales $21.554M Beat $19.154M Estimate 
Carlsmed Raises FY2026 Sales Guidance from $74.000M-$78.000M to $78.000M-$80.000M vs $76.944M Est 
Carlsmed® Reports Third Quarter 2026 Financial Results and Raises Full-Year Guidance 
Carlsmed, Inc. to Report Third Quarter 2026 Financial Results on November 10, 2026 
Carlsmed Launches aprevo® Lumbar Bi-lateral Posterior System
Your note
Sign in to keep a note on CARL — it syncs with the Stock Master app.